Hyperphosphorylation of human TAU by brain kinase PK40erk beyond phosphorylation by cAMP-dependent PKA: relation to Alzheimer's disease
- PMID: 8166686
- DOI: 10.1006/bbrc.1994.1432
Hyperphosphorylation of human TAU by brain kinase PK40erk beyond phosphorylation by cAMP-dependent PKA: relation to Alzheimer's disease
Abstract
Abnormal hyperphosphorylation of the cytoskeletal protein TAU is seen in the characteristic paired helical filaments [neurofibrillary tangles] of Alzheimer's disease [AD]. A recently described protein kinase, PK40erk, (1) a member of the ERK family of kinases, can produce in vitro many of the properties of Alzheimer-like hyperphosphorylated TAU. cAMP-dependent protein kinase A [PKA] phosphorylates TAU to a lesser extent; however, the product is not like the hyperphosphorylated TAU of AD in several important respects. We now report that in vitro PK40erk, a candidate for the enzyme responsible for TAU hyperphosphorylation in AD, will further phosphorylate TAU that was previously saturated by protein kinase A, provided that the concentrations of free uncomplexed ATP are low. Interestingly, the actions of different kinases on TAU are not independent, but may depend on the order in which they work on TAU; i.e., prior phosphorylation by PKA partially inhibits the action of PK40erk.
Similar articles
-
Brain protein kinase PK40erk converts TAU into a PHF-like form as found in Alzheimer's disease.Biochem Biophys Res Commun. 1993 Jun 15;193(2):639-47. doi: 10.1006/bbrc.1993.1672. Biochem Biophys Res Commun. 1993. PMID: 8512563
-
Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments.Biochemistry. 1999 Mar 23;38(12):3549-58. doi: 10.1021/bi981874p. Biochemistry. 1999. PMID: 10090741
-
Tau therapeutic strategies for the treatment of Alzheimer's disease.Curr Top Med Chem. 2006;6(6):579-95. doi: 10.2174/156802606776743057. Curr Top Med Chem. 2006. PMID: 16712493 Review.
-
Phosphorylation of tau by cyclic-AMP-dependent protein kinase.Dementia. 1993 Sep-Oct;4(5):256-63. doi: 10.1159/000107331. Dementia. 1993. PMID: 8261023
-
Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.J Biochem. 1997 Feb;121(2):179-88. J Biochem. 1997. PMID: 9089387 Review.
Cited by
-
Tau potentiates nerve growth factor-induced mitogen-activated protein kinase signaling and neurite initiation without a requirement for microtubule binding.J Biol Chem. 2010 Jun 18;285(25):19125-34. doi: 10.1074/jbc.M110.105387. Epub 2010 Apr 7. J Biol Chem. 2010. PMID: 20375017 Free PMC article.
-
Sexual dimorphism in predisposition to Alzheimer's disease.Neurobiol Aging. 2018 Oct;70:308-324. doi: 10.1016/j.neurobiolaging.2018.04.004. Epub 2018 Apr 17. Neurobiol Aging. 2018. PMID: 29754747 Free PMC article. Review.
-
Sex differences in chronic stress responses and Alzheimer's disease.Neurobiol Stress. 2018 Mar 26;8:120-126. doi: 10.1016/j.ynstr.2018.03.002. eCollection 2018 Feb. Neurobiol Stress. 2018. PMID: 29888307 Free PMC article. Review.
-
Hyperactivation of mitogen-activated protein kinase increases phospho-tau immunoreactivity within human neuroblastoma: additive and synergistic influence of alteration of additional kinase activities.Cell Mol Neurobiol. 1999 Apr;19(2):249-60. doi: 10.1023/a:1006981228331. Cell Mol Neurobiol. 1999. PMID: 10081608 Free PMC article.
-
Activation of a neurofilament kinase, a tau kinase, and a tau phosphatase by decreased ATP levels in nerve growth factor-differentiated PC-12 cells.Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):1861-5. doi: 10.1073/pnas.92.6.1861. Proc Natl Acad Sci U S A. 1995. PMID: 7892192 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
